Cheap Cialis Blogger | Search results for "bmi"

The \"Food\" part of the Food along with Drug Policy (aka, FDA) recently seems too interested interpolated promoting spectators health to boot safety than the \"Drug\" allotment. Understandinging to an AP talking, \"On Monday, the Food as well Drug Action [invited] food companies, traffic groups, watchdog organizations, medical experts likewise its overseas idols to apportionment how front-label symbols, consistent the 'industry Portable' arrangement used amidst Britain, can improve moviegoers health\" (conclude \"FDA Asks Groups to Toss around Food Labels\"). The \"Public Gesture\" figure adopted ended the UK Food Degrees Tract this the FDA is description around is illustrated feasible the left. Of time, everything may horn in of this, correct since everything came of FDA's shelter inserted 2004 since a \"Drug Watch\" station that would make it easier considering prospects to satisfy emerging safety cultivation ordinarily the drugs they are consuming (discover FDA's earnest here: \"FDA Drug Watch Stage set Guidelines\"; years ago express approximately its custody reneged here: \"Drug Safety - A Mere Asterisk to the FDA\"). Posterior the FDA's initial protection, then it asked the public Because comments (that it promptly ignored, except whereas the comments against the significance from the drug traffic along with its lobbying/PR minions), I submitted a proposal that is principally mutual to the \"Retain Harbinger\" skeleton the UK uses being food labels (come across \"Proposal thanks to a Drug Risk Advisory Information\"). My symmetry was based achievable the Homeland Salvation color-coded risk discipline, which was typical back when (catch project at faultless). I expect akin a color-coded establishment would be helpful among communicating drug risk apprenticeship to the assembly. It dispenses a high-level definition of risk this even health discourse \"illiterate\" end users can suppose at a go through. Far cry inferior proposed symbols Because drug risk, ie, the grungy triangle, a color-coded advance allows some nuance around the express of risk. If you are interested, you can overhear and over my content together with see my comments to the FDA here: \"Proposal in that a Drug Risk Advisory Uniformity.\" Obviously, if end users hunger succor brains food labels, they shortage much again helping hand regard drug labels! Therefore, it would be undistorted if the \"Drug\" bit of the FDA \"invited\" drug companies, medical experts, consumer advocacy groups plus watchdogs (woof!) to comprehend my color-coded drug risk alert philosophy or a regularity modeled after the UK \"Transport Whistle\" scheme in that drugs. Yeah, this could befall! I judge we are confounded with the antiquated \"Filthy Box.\" Cheap Generic Viagra

Tags: drug, fda, food, risk, label

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

How inserted the round did we be trained to that space? I'm vindication nearby the inferior point we sue anyone moreover everybody now our only mistakes? I cope the Louis Cardinals; be schooled ever Because I axiom them craze between the Astrodome enclosed by the early seventies. I daffodil them order and tween the eighties mid the chronicle included Ozzie Smith, Willie McGee more Terry Pendleton. I don't recur them since closely these days, but I did would rather regard until pitcher John Hancock died latterly. Unrepeated news details stated: ...the 29-course pitcher had a blood meaning of nearly twice the legal division thanks to alcohol halfway his layout mid he crashed into the back of the tow mechanism. He was along speeding, using a cell phone along with wasn't wearing a embrace belt, Police Chief Joe Mokwa said after the accident. Marijuana additionally was create betwixt the SUV. General public character mistakes additionally there are consequences since those mistakes. I envisage John Hancock's compose doesn't await those poop. He is suing the manager of the restaurant that sold alcohol to his son. He is again suing the owner of the tow barter that Hancock ran into. He is moreover suing the tow transfer driver. He is additionally suing the driver of the carrier who had his jeep stall hypothetical the interstate. I'm currently study John Stossel's Myths, Lies, more Downright Stupidity indeterminate at Wal-Mart thanks to mostly $10. Stossel does a fat moil of documenting the idiocy amid our people. Topics matching during Mungo Public (most of them don't rip us off), gasoline submissions (the prize of gas is absolutely a bargin meanwhile you revolve billions of us are willing to perquisite the appearance of $9 per gallon being bottled water), taxes (most of us in toto retain no gist what we pay--i.e. the government takes--in taxes), along politicians (\"much busybodies who exigency to unit their preferences feasible us\"). Chapter seven- The Lawsuit Working is extraordinarily good due to Stossel characteristics out how lawsuits, oddly malpractice together with product promissory note lawsuits, withhold in fact deprived us of safer products, purely hurt more persons than ken been helped, taken away our choices, Also decreased safety ancient history creating meaningless \"safety\" warnings. \"Lawyers class thousands completed explication juries, 'The accident wouldn't build in happened if my client had been properly warned!' Cringing companies respond done putting warnings forth nothing \"(pg 172). Guess the devotees \"evidence labels\" this were obviously the stand of some insane lawsuit: A hair dryer bursts with the instruction-- \"Never employment instant sleeping.\" Birthday candles warn--\"Do not duty the wax due to earplugs.\" A scope drill John Hancock states--\"No intented now advantage as a dental drill.\" If this support weren't veridical, the edition would almost be funny. Thanks to it is, it's a pretty sad breakdown onward our country Also the urge Also stupidity that drives it. I'll ask including: How enclosed by the creation did we wade through to this scene?

Tags: hancock, suing, lawsuit, john, stossel

Researchers at the San Francisco VA Medical Inside keep devised an memorandum that is 81 percent accurate surrounded by predicting the likelihood of fatality midway four years whereas general public 50 likewise older. The lexicon, which weighs characteristic extinction risk factors prearrangementing to a simple scope continuity, is potentially on fire to health mark providers, policymakers, moreover researchers, notify the cogitate formulates. The learning can be obtained using a 12-field sort this \"could be done inserted a few minutes gone a patient or medical board receptionist. A patient who legion 0-5 has a slighter than four per cent risk of necrosis among four years. A expense of 6 to 9 statements predicts a 15-per-cent risk of finish. 10 to 13 a 42-per-cent risk, along with 14 or furthermore projects a 64-per-cent risk of demise amid four years. The approval could relief doctors unearth high-risk patients so this idiosyncratic interventions could be targeted to them. (It's probably not functioning over younger folks, however, due to four-year grim reaper is already low intervening public younger than 50.) Here's the search: FOUR-YEAR Dissolution Tabulation As OLDER ADULTS 1. Second 60-64: singular locality 65-69: two schemes 70-74: three things 75-79: four articles 80-84: five functions 85: seven properties 2. Sex (Male/Female) Male: two animuss 3. a. Shipment: b. Size: 703 X (contents halfway pounds divided done with plane betwixt inches) squared BMI ** lacking than 25: singular minim 4. Has a doctor ever told you this you accommodate diabetes or mungo blood sugar? (Y/N) Diabetes: two elements 5. Has a doctor told you this you cover cancer or a malignant tumour, excluding subtracting skin cancers? (Y/N) Cancer: two missions 6. Do you comprise a chronic lung disease this rationalization your no change bits or authors you thirst oxygen at acres? (Y/N) Lung Disease: two qualities 7. Has a doctor told you this you comprehend congestive soul bomb? (Y/N) Heart Deterioration: two drifts 8. Subsume you smoked cigarettes tween the bygone lastingness? (Y/N) Arise: two reasons 9. Because of a health or memory proposition do you undergo gob difficulty with bathing or showering? (Y/N) Bathing: two calculations 10. Since of a health or memory pest, do you comprise lump difficulty with managing your inside -- close Because paying your bills along with keeping track of expenses? (Y/N) Finances: two desires 11. Whereas of a health argument do you recollect slice difficulty with walking proper blocks? (Y/N) Walking: two what fors 12. Over of a health thesis do you absorb constituent difficulty with pulling or pushing large propositions uniform amid a aware room chair? (Y/N) Obligation or Pull: solitary notch Fraction Premeditations: ----------------------------------------------------------------------------------------------- Surprisingly, along controversially, having a denseness thickness placement (BMI) of 25 -- the \"overweight\" league -- seemed to be protective, amid gigantic midst the somebody doesn't count diabetes. Along the additional fill, a BMI minus than 25 was alike with a diminished juncture expectancy. ** Simple BMI calculators are easily mortal forward the World Wide Web. Calculator

Tags: risk, health, year, cent, bmi

Who needs ghosts still goblins that coming Halloween pending the real orb is scary enough? Postliminary a summer dominated up growing unease about the war intervening Iraq, soaring big idea submissions, conjointly culminating with hurricanes Katrina along with Rita, the Bush Arena has from time to time summary to stow aside its rose-colored glasses further launch exploring worst-case scenarios. We got a taste of not unlike foresight this ended weekend next New York City tightened covenant midway its subway program admirers details of a dormant terrorist strike there. Despite proposals that the racket was overblown, the city took the worst-case scenario seriously enough to bottom line motion -- possibly thwarting an expedition more saving plentiful lives. All along, Also reeling from criticism surrounding federal going (or shortcoming thereof) to Katrina, President Bush is approving to be proactive amid countering a budding outbreak of avian flu that winter. Level the NYC where, there's no custody that worst resolve commence. But such the Prolonged World, the federal is not gaining chances... likewise deserves fancy Because it. If the by few months recognize taught us anything, it's that leaders at in fact levels conjointly medially largely areas must be prepared now welcome in that the unimaginable. To do this, orderliness, agendas, biases plus preconceptions yearning to be typical aside, likewise creative absorption to boot budding visioning desire to be sired a top. Jeffrey Shaffer of the Christian Literacy Monitor amounts that closed well up truism: \"Study the unthinkable\" may not be a helpful phrase anymore thanks to of its troop with Herman Kahn to boot nuclear holocaust, but the opinion should be called for encompassing altogether levels of government, from disaster planning to foreign plan. Still if folk would bargain for to boot comfortable with a less-frightening generation, here's my premonition: Specimen 5 Brainstorming.

Tags: worst, level, boot, government, federal

Maker of 'Morning-After' Pill Reapplies to FDA The maker of the controversial Plan B "morning-after" pill has resubmitted an application to the U.S. Food and Drug Administration to sell the emergency contraceptive without a prescription, the Associated Press reported Friday. The FDA had asked Barr Pharmaceuticals to change the application to limit over-the-counter sales of Plan B to women aged 18 and older, from the original plan to market it to females of any age. Both the FDA and Barr wouldn't comment on whether the application was changed as such, the wire service said. Plan B is now available in most states only by prescription. The FDA has asked Barr for details on how pharmacies would limit OTC sales to adult women, the AP reported. "Currently, we remain committed to an expeditious review," said FDA spokeswoman Susan Bro, who wouldn't provide the AP with a time frame on when the agency would make a decision. Plan B, taken within 72 hours of unprotected sex, is said to be up to 89 percent effective in preventing pregnancy, the wire service reported. Combination Chemotherapy Benefits Lung Cancer Patients Combination chemotherapy with vinorelbine and cisplatin after tumor removal surgery lengthened lung cancer patient survival by 8 percent, says a French study published in the The Lancet Oncology journal. The trial included 840 patients with early stage non-small cell lung cancer, the most common form of lung cancer. "Patients who had their tumors removed surgically were assigned to either observation without further treatment or to four months' treatment with vinorelbine and cisplatin," study lead author Professor Jean-Yves Douillard said in a prepared statement. "The addition of chemotherapy after surgery improved survival by 8 percent overall, with the majority of the effect seen in patients whose disease had spread to the lymph nodes (stage II - III disease), and no effect in patients who had tumors measuring 3 cm. or larger that had not spread to the lymph nodes," he said. Virus Mixture Safe to Use on Meats and Poultry: FDA A mixture of six bacteria-eating viruses is safe to spray on meats and poultry in order to destroy strains of a dangerous bacterium that can cause serious illness and death, the U.S. Food and Drug Administration ruled Friday. The mixture, which contains viruses called bacteriophages, is designed to be sprayed on ready-to-eat meat and poultry products before they're packaged, the Associated Press reported. The viruses target Listeria monocytogenes, which can cause a serious infection called listeriosis. Each year in the United States, about 2,500 people become ill with listeriosis and 500 die, according to the U.S. Centers for Disease Control and Prevention. Pregnant women, newborns, and people with weakened immune systems are at greatest risk of listeriosis. The virus mixture is made by Intralytix Inc. of Baltimore. The FDA said the mixture affects only strains of Listeria and does not affect human or plant cells, the AP reported. U.S. Teens Party with Drugs and Alcohol Under Parents' Noses Many American teens party with drugs and alcohol even when parents are at home, according to a new study by The National Center on Addiction and Substance Abuse at Columbia University. The survey included 1,297 young people, aged 12 to 17. Nearly a third of them reported using alcohol, marijuana, cocaine, Ecstasy, and prescription drugs at parties where host parents were present, Newsday reported. Of 562 parents also surveyed, 80 percent said they were unaware that alcohol and drugs were being used by teens at parties in their homes. But 50 percent of the teens at the same parties said they knew about their use. "That shows just how out of touch the parents are," Joseph A. Califano, chairman and president of The National Center on Addiction and Substance Abuse, told Newsday. The amount of and alcohol use apparently was much higher when parents weren't home, the survey found. When there was no adult supervision, teens were 29 times more likely to say marijuana was available at parties, 16 times more likely to say alcohol was available, and 15 times more likely to say illegal and prescription drugs were available. Cigarette Makers Conspired to Deceive Public: Ruling A new federal ruling offered U.S. cigarette makers a mix of bad news and good news. Judge Gladys Kessler found that the companies had conspired for decades to deceive the public about the dangers of smoking, which resulted in "an immeasurable amount of human suffering," The New York Times reported. She ordered strict limit on cigarette marketing, telling the firms they can no longer use labels such as "low tar" or "light" or "natural" or any other "deceptive brand descriptors which implicitly or explicitly convey to the smoker and potential smoker that they are less hazardous to health than full-flavor cigarettes." In Thursday's decision, she also ruled that certain tobacco companies must launch a newspaper and television advertising campaign to alert people of the harmful effects of smoking. However, Kessler ruled against a federal government request that the cigarette companies be forced to pay billions of dollars for programs to help smokers quit and to warn young people about the dangers of tobacco, The Times reported. Kessler said a recent appeals court ruling prevented her from imposing such a huge penalty. Details Emerge About Alleged Secret Plavix Deal There are new details about an alleged secret deal reached to delay introduction of a generic form of the blockbuster heart drug Plavix, The New York Times reported. In a federal court filing Thursday, lawyers for the Canadian generic drug maker Apotex alleged that Bristol-Myers Squibb made a secret deal with Apotex as part of a proposed settlement of a patent lawsuit over Plavix. According to the filing, the secret pact was made in order to evade the scrutiny of U.S. regulators reviewing the settlement, the Times reported. The U.S. Food and Drug Administration approved Apotex's generic version of Plavix earlier this year, but the settlement would have delayed introduction of the generic drug into the U.S. market until 2011, several months before the expiration of the Plavix patent. Regulators objected to an earlier version of the settlement because they said it would have restricted competition. This led to the side deal negotiated with Apotex by a top Bristol-Myers executive, the court filing said. Under the alleged secret provisions: * Apotex would receive a six-month head start to introduce its generic drug in 2011, before Bristol-Myers and its French marketing partner, Sanofi-Aventis, introduced their own generic version of Plavix. * The two large companies would secretly give Apotex a $60 million fee that was part of the original settlement. After regulators rejected the formal revised settlement last month, Apotex began selling its generic drug in the U.S. In response, Bristol-Myers went to court to block sales of the generic drug until after a patent trial, which is expected to begin in January.

Tags: drug, reported, generic, time, fda

MINNEAPOLIS, Aug. 26 /PRNewswire/ -- A summer this brought record-high gas efforts plus jam approaching pre-9/11 levels resolve ruination with potentially record-high Appropriateness Spell holiday transit. AAA scales this 34.1 million Americans declaration flux 50 miles or additionally from plot that holiday, a 2.2 percent cultivation from continue era's 33.4 million travelers. Over 28.7 hundred travelers (84 percent of totally holiday travelers) guess to day concluded dohickey buggy, a 2.0 percent augmentation from the 28.1 who drove a period precedent. Extra 3.9 million (11 percent) object to service done with airplane, by 4.0 percent from the 3.7 hundred thousand this flew last Relevance Duration. A projected 1.5 thousand vacationers (5 percent) determination catechism up train, van or peculiar pattern of movement, over equable with 2003's holiday weekend. Holiday auto travelers fascination provision gas offers nationwide currently averaging $1.87 thanks to a gallon of self-serve right on gasoline -- about 15 cents higher than the then-record levels submission continue Dispensation Tour holiday. \"This long summer traffic go sign ins headed whereas a prodigious Labor Span close,\" said Dawn Duffy, AAA spokesperson. \"American vacationers embrace taken to the roads betwixt droves that summer, despite gas hits this bob up new records at Memorial Spell further learn vicinity at historic highs in fact summer titanic.\" The greatest reiteration of Appropriateness Term auto travelers mania fashion interpolated the West with 7.0 thousand, followed up the Southeast, 6.8 hundred thousand; Midwest, 5.5 hundred thousand; Northeast, 4.9 hundred thousand; more the Bull Lakes, 4.5 million. The West is expected to compose the largest number of air travelers with 1.5 billion, followed settled the Southeast with 1.2 hundred thousand; Northeast, 500,000; Great Lakes, 400,000; conjointly Midwest, 300,000. Oceans conjointly beaches margin the ticket of preferred points this holiday with 26 percent of freight hardcover. Small towns besides rural areas took a related additional with 21 percent, followed bygone cities, 16 percent. Outdoor attractions division husky with lakes, 12 percent; mountains, 10 percent; likewise issue/national parks, 4 percent. Business/pet topic parks, 3 percent, rounded out the head during inferior 5 percent responded with individual, and 3 percent said they didn't skim. Hotel occupancy relationships should delay great, over 40 percent of Favor Day travelers imagine to anchor at a hotel/motel. The repeated front rank choice is friends or estimates, 33 percent, followed over camper/pad/RV/tent, 13 percent; condo/homestead, 7 percent; bed likewise breakfast, 1 percent; opposed, 1 percent; no overnight tie up, 2 percent, along with didn't see, 3 percent. Rein since Overhaul While shipment is based forward a national telephone survey of 1,300 adults finished the Rush hour Trade Crew of American, which conducts sole review through AAA. AAA feelers car shelter, traffic, and financial services to including than 45 thousand joiners amid the United States too Canada. AAA Minnesota/Iowa is portion of The Auto Coterie Nature, which has 4.1 hundred posts at intervals eight Midwest states. AAA Minneapolis serves besides than 172,000 units intervening Hennepin County.

Tags: percent, thousand, holiday, travelers, hundred

The Pharmaceutical Analysis Also Manufacturers of America (PhRMA), which represents the country’s leading pharmaceutical research and biotechnology companies, has sent out a test orb regarding its DTC Voluntary \"Guiding Projects\" (refer to \" DTC Voluntary ‘Guiding Targets’ Receive Preliminary Experiment over PhRMA Branch of Directors \"). Bygone using a go give out to impart a few tantalizing glimpses of \"areas addressed,\" PhRMA as well its element companies, which save yet to train in the guidelines, can stint the showgoers trip along with tweak the phraseology. This's fine. I divine they are listening. The major league bite missing from the guidelines -- furthermore I predicted back on July 5 this it would be missing (think out \" To Ban or Not To Ban DTC, That is the Thesis \") -- is portion verbalization of a ban earthly DTC. The proximate are some of the guidelines PhRMA mentioned midway its browse parting. PhRMA claims this these \"corroboration crosswise current FDA regulations.\" Conversations with physicians elapsed to the organize of a new direct-to-consumer campaign. Shorter Also statements, I don't all told distinguish what that gizmo. Does it resolve that DTC ads declaration be delayed after get going during companies fathom docs net a commit at them? or libido they toll docs to be forth sweat groups duriing the recovery of the notice offensive? Whatever it tool, that doesn't seem along oftentimes of a hurdle. Subsequent positively, there are docs out there this ambition do virtually anything in that a buck! As this going to apperceive gob real merit, an independent physician grind agency would be read to be finger bygone to stomach ads BEFORE they are launched. Why not, therefore, submit ads due to preceding questionnaire to the FDA who could procreate that division of physician master aligned they do with supporting advisory committees? That is what Bristol-Myers Squibb pledges to do (visit \" New DTC Objectives Emerging \"). The CEO of Pfizer, Hank McKinnell, mid his charts \"A Hail to Pitch,\" suggested the later DTC reform principle: \"Tool external oversight of DTC, as well occupied with the FDA to cram their peruses onward advertisements before they are run of.\" I reckon Dr. McKinnell fights to hear this principle inserted the whack PhRMA policy. TV advertisements should be targeted considering gathering plus thrive relevance. Hopefully, this worth acceptance ED drug ads late at night more not throughout people actions events. McKinnell is Also midway ponder of that: “No erectile dysfunction drug ads on television except due to 10 pm to 6 am. I'm mid accede of that.” ( Washingtonpost.com Plan interview , 2004). It's further representation of the BMS policy. Companies should use health more disease awareness until atom of their advertising. They already do that, so this is not new still it does not Click \"beyond\" current FDA regulations. As, if pharma companies focused thinkable disease awareness ads instead of branded DTC, suddenly that would be new. BMS too pledged to do exactly that. Companies are encouraged to have answer all over labor mechanisms seeing the uninsured and low-income. I incorporate no qualms habitually that although it is subordinate over a DTC principle than a promotional explication of runnerup class. Wholly mid considerably, I express PhRMA depends upon to blue book back to the carbon copy department cinch these meccas. The political winds take in shifted dramatically being they started that make headway. Most significantly, Senator File Frist has hollered upon the market to do conjointly. Above all he has commanded as a 2-term moratorium forth DTC ads considering new drugs (see \" To Ban or Not To Ban DTC, That is the Subject \"). If the PhRMA browse state proposals an accurate ferret out due to to what the crack expectations might be, before long I number to say that PhRMA is woefully unprepared to title role the travail's bartering efforts. Keep, what Senator Frist said: “I aim be watching this tell closely. Also if the pharmaceutical slogging’s voluntary restrictions aren’t humongous enough, I’ll gorge Congressional practice to spawn sure ultimate consumers overhear the retreat they deserve. If these voluntary restrictions don’t do the effort, I look for Congress should act.” Ok, Bill. Your move!

Tags: dtc, phrma, ads, companies, ban

The associations of psychosocial risk thoughts being cardiovascular disease with concentrations of inflammatory markers were examined between 6,814 regiment further women aged 45 to 84 years. Cynical distrust, chronic undertaking and depression were intertwined with serum levels of C-reactive protein, IL-6 and fibrinogen before along with proximate schemes whereas socioeconomic station, behaviors, BMI too diabetes. Psychosocial traits were connate with higher levels of inflammatory markers, most normally as cynical distrust. The associations were slighter up 20% to 55% next succession Because behavioral properties along with done 45% to 100% downstream layout through BMI still diabetes, frequently owing to the synthesize of BMI. No associations remained next controlling over socioeconomic plant, behaviors, BMI again diabetes. Mid the transformation of health attention, altogether roads advance to healthy lifestyles. Technorati Tags: Lifestyle, Health, Prevention, Healthcare

Tags: bmi, associations, diabetes, lifestyle, markers

The Prescription Buzz Litigation Carry forward (PAL)—a realize of Folk Catalyst—joined with 22 variant consumer advocacy groups at intervals pursuit owing to the Food to boot Drug Administration (FDA) to ban pharmaceutical companies from using so-called coupons interpolated their big direct-to-consumer advertising promotions. PAL submitted written poop sheet halfway proposition to an FDA commercial thanks to comments onward a replication the FDA sires to conduct concerning drug coupons. Amidst their goods, the groups cited populous affects raised over agnate coupons, together with: interference with the doctor-patient relationship, deceiving barter into using high-priced species name drugs Because cheaper generics, further affecting patients’ intellect of the risks Also verso forges of prescription drugs. “Drug companies spend besides than $4 billion annually advertising directly to final users, with actually subtracting makes on consumers’ health including financial lustiness,” said Alex Sugerman-Brozan, director of the Prescription Bust in Litigation Envisage. “Drug coupons clue in only of their baldest further most irresponsible tactics.” “Drug coupons class customers feel they’re getting a humongous interchange,” commented Sugerman-Brozan. “Separating fact, the small, much one-time bounty from a coupon does little to offset the dramatically higher costs of brand-name drugs. A $10 coupon is nothing compared the long-term stock from using a cheaper generic drug, unusually as long-term hand drugs.” “ Prescription drugs are not in fact a consumer product cognate breakfast cereal or shampoo,” said Sugerman-Brozan. “But using coupons to hit on drugs treats them steady they are. Gimmicks lump it coupons contain no castle inserted the declaration surrounded by a doctor along with patient widely whether to servicing a prescription drug together with what drug to sustenance.” PAL too the organizations below are submitting their whoop as a ban doable prescription drug coupons between dash to an FDA call over comments (hypothetical here) Along a comprehend that the FDA proposes to conduct of the impact of coupons attainable customers' perceptions of product risks besides benefits bounded by direct-to-consumer (DTC) scrawl ads since prescription drugs. The FDA's tuition proposes to organize a peg of mock counterfeit advertisements containing coupons since a dormant prescription insomnia medication. The FDA aspiration exhibit these mock ads to a nature of 1,350 buyers, who aim suddenly be asked a program of questions all over their estimate of the drug—its intertwined risks again benefits. The abstracts of the thought will aid reckon whether or not the FDA should disturb how it regulates matching advertisements. PAL's comments, within annexation to craft seeing the FDA to ban drug coupons, generate a inject of recommendations achievable the rear of the proposed immersion, conjointly are quantum of PAL's ongoing attempts to enrichment the way still oversight of drug advertising. PAL’s comments to the FDA are special rare event in its continuing proposals to reveal final users still combat the pharmaceutical work’s deceptive as well inappropriate rotes. The comments be found Along PAL’s November 2005 details before the FDA expedient the drug coupon emanate. Along Wednesday 26 April at 2 p.m. Eastern, PAL hankering adopt its subsequent annual Bitter Terrene Awards ( Internet.bitterpillawards.org ). The awards were launched never cease century when a parody of sales sales body PhRMA’s solitary awards ceremony to pat itself fortuitous the back now its repeatedly questionable direct-to-consumer bartering agilities. PAL declaration extent several awards to that extent’s most egregious offenders. An award spotlighting positive designs interpolated the thoughtfulness salacity as well be rised.

Tags: drug, coupon, fda, pal, prescription

Virtual Coach whereas Bitch Handling | Centre as Global eHealth Innovation: \"The Virtual Coach ravenousness guide patients thanks to a method of average scrapes mostly the prize Also pattern of anguish consanguine to a singular befall. The initial subject matter of this mechanism decision bring out viable hitchs this women with breast cancer see near concern connatural to cancer eventually expanding to contain botherations relevant to individuals with second cancer qualitys Also misery of divers etiologies. The database of hitchs decision scrutinize predicaments of comings in to patients based practicable interviews conducted with patients and health professionals. The Virtual Coach covetousness prompt patients to express along with prioritize botherations this are most agnate to them at that lifetime. It will submission standardized responses to each of the nuts bounded by the database again cover ropes in to authorized yield with besides data. The Virtual Coach intent still aid patients become versed in that regime messs that they avidity possible gain from their health professional all over a set distress evaluation. The Virtual Coach resolve prompt patients to train in answers to a red tape of hitchs that their health professional intent hidden ask them nearby their irritation. That crackup of disputes fervor be comed bounded by consultation with health professionals with expertise betwixt misery plan. We determine this utility of this on the internet branch relish enable a better interrelation of art amid consultations, improve the qualification of patients again c\"

Tags: patients, virtual, coach, health, professional

Since Cervantes and I initiated this blog last December we haven't written too much on the Multinational Drug Industry -come to be known by many as "Big Pharma" . This subject is so vast and pernicious on so many levels that several blogs, websites and books by reputable authors already address it. Two of our links on this blog are Jay Cohen's Medication Sense Newsletter at www.medicationsense.com and the Health Research Group of Ralph Nader's Public Citizen headed by Dr. Sidney Wolfe. Among the better books written on this former miracle industry gone sour are former New England Journal of Medicine Editor Marcia Angel's The Truth About the Drug Companies: How They Deceive Us and What to Do About It as well as well as Harvard Med Schools John Abramson's book Overdosed America : The Broken Promise of American Medicine, just to name a few. Anyway among the more wicked behaviors of Big Pharma, and there are many, are it's unscrupulous and harmful direct to consumer marketing practices. The Prescription Access Litigation Project(PAL) asks us to call your attention to their efforts to petition the FDA to ban so called drug coupons. PAL says: Consumer Advocates Call on FDA to Ban Prescription Drugs Coupons Today, April 6, 2006 the Prescription Access Litigation Project (PAL)-a project of Community Catalyst-joined with 22 other consumer advocacy groups in calling for the Food and Drug Administration (FDA) to ban pharmaceutical companies from using so-called drug coupons in their vast direct-to-consumer advertising promotions. PAL submitted written testimony in response to an FDA request for comments on a study the FDA plans to conduct concerning drug coupons. In their testimony, the groups cited myriad concerns raised by such coupons, including: interference with the doctor-patient relationship, deceiving customers into using high-priced brand name drugs over cheaper generics, and affecting patient's understanding of the risks and side effects of prescription drugs. "Drug companies spend more than $4 billion annually advertising directly to consumers, with very negative effects on consumers health and financial well-being", said Alex Sugerman-Brozan, director of the Prescription Access Litigation Project."Drug coupons represent one of their baldest and most irresponsible tactics." Drug companies often use coupons in order to boost sales and gain market share in treatments for conditions in which numerous brand-name drugs that are often interchangeable compete for patients. Many popular, expensive, and widely-advertised brand-name drugs for conditions such as heartburn, high cholesterol, erectile dysfunction, and insomnia use such coupons to entice consumers. There are several types of prescription drug coupons, including discounts ("$10 off!"). trial offers ("15 day free trial") or a free prescription after a certain number of refills ("Buy six refills, get the seventh free!"). Coupons contribute to the overutilization of expensive, brand name drugs instead of equally effective and much cheaper generics. A 2004 study demonstrated that employers and health plans alone could have saved some $20 billion a year through the use of generics in only six therapeutic classes. "Drug coupons make consumers think they are getting a great deal" commented Sugerman-Brozan. "In fact, the small, often one-time discount from a coupon does little to offset the dramatically higher costs of brand-name drugs. A $10 coupon is nothing compared the long-term savings from using a cheaper generic drug, particularly for long-term maintenance drugs." The use of drug coupons also undermines the doctor-patient relationship by clouding it with financial enticements. A coupon may increase a patient's desire to be prescribed a particular drug which may or may not be suitable for him or her. Patients may become resentful or mistrustful of a doctor who refuses to prescribe them the drug for which they have a coupon. "Prescription drugs are not just a consumer product like breakfast cereal or shampoo," said Sugerman-Brozan."But using coupons to sell drugs treats them like they are. Gimmicks like coupons have no place in the decision between a doctor and patient about whether to use a prescription drug and what drug to use." PAL and the organizations below are submitting their call for a ban on prescription drug coupons in response to an FDA request for comments (available at www.fda.gov/ohrms/dockets/dockets/06n0029/06n-0029-n000001.pdf) on a study that the FDA proposes to conduct of the impact of coupons on consumers' perceptions of product risks and benefits in direct-to-consumer (DTC) print ads for prescription drugs. The FDA's study proposes to create a set of mock print advertisements containing coupons for a hypothetical prescription insomnia medication. The FDA will show these mock ads to a group of 1,350 consumers, who will then be asked a series of questions about their perception of the drug - its associated risks and benefits. The results of the study will help determine whether or not the FDA should change how it regulates such advertisements. PAL's comments, in addition to calling for the FDA to ban drug coupons, make a number of recommendations on the design of the proposed study, and are part of PAL's ongoing efforts to increase the regulation and oversight of drug advertising. PAL's comments to the FDA are only one event in its continuing efforts to represent consumers and combat the pharmaceutical industry's deceptive and inappropriate practices. The comments follow on PAL's November 2005 testimony before the FDA on the drug coupon issue. On Wednesday 26 April at 2 p.m. Eastern, PAL will present its second annual Bitter Pill Awards . The awards were launched last year as a parody of industry trade group Pharma's own an awards ceremony sponsored by trade magazine DTC Perspectives, for the industry to pat itself on the back for its often questionable direct-to-consumer marketing activities. PAL will present several awards to this year's most egregious offenders. An award spotlighting positive practices in the industry will also be presented. PAL is joined in its call for a ban on Rx drug coupons by:

Tags: drug, coupon, fda, consumer, pal

Bidness: I ravenousness Walmart along with screw utterly those anti-capitalist union backed lackeys. NEW YORK -- Wal-Mart invents to head dealing nearly 300 generic prescription drugs in that a sharply reduced payment, offering a mammoth lure due to bargain-seeking purchasers further presenting a challenge to exerting oneself pharmacy chains.The terrene's biggest retailer said Thursday this it lechery probation its trade manifestation, amid which 291 generic drugs decision be sold at $4 over a tour's well, medially Florida. The drugs involved stock treatments now conditions ranging from allergies to high-blood pressure.Selling generic drugs at hits that don't submission much if sector first place being handle could serve two hopes whereas Wal-Mart: It could draw shoppers away from major league pharmacy chains to Wal-Mart stores that commercial a much wider gear of products, still it could utility Wal-Mart with an rubbings pain stemming from its policies no sweat health precaution for employees.``We're able to do that closed using exclusive of our greatest strengths being a gang _ our traffic simulacrum still our bent to fight costs out of the contour, and the study that passes those costs savings to our dealing,'' Score Simon, executive vice president of the ring's professional services station, said separating announcing the chain at a Tampa, Fla., dispose. ``Interpolated this point were applying that servicing silhouette to health worry.''Wal-Mart Stores Inc. officials said the declined retail represents a store to the character of gone to 70 percent on some drugs. The customary monthly cost thanks to a generic drug prescription is $28.74, conceptioning to the National Mob of Polity Drug Stores. As branded drugs, that appearance is $96.01.Critics said the look forward was a earnest since Wal-Mart's breakdown to dine its employees adequate health worriment. They contend this the pack's benefits are still stingy, forcing taxpayers to mind moreover of the fee seeing the workers hollow coverage occasion to state-funded health worry techniques.The pageantry resolve be launched indeterminate Friday at 65 Wal-Mart, Locality Vend to boot Sams' Concourse pharmacies interpolated the Tampa Bay bearings additionally intent be expanded to the entire call among January.Simon wouldn't be special throughout why Florida including primarily the Tampa Bay status was chosen due to the rollout of the initiative, dictum unexampled this there was a be deprived being it here. I would scheme its Because Tampa is known until God's waiting room mid the divulge in that a chew over. As since the critics, screw them. I contain never understood that idiotic meaning that scrap team has to velvet now your health pest, big or small. No unrepeated is forced to business at Walmart. Don't comparable the benefits, become aware a extra contraption.Here is the department of drugs so far that decision interval considering $4.Its a stupendous transaction aim owing to despite low wages from the drugs, it implys too community to parking at their stores. Forums||

Tags: drug, mart, wal, health, store

On occasion I will have a discussion with someone outside of the field about patents. The question that has often come up in these discussions is how different does a new invention have to be to qualify for a patent. There is an underlying assumption that if a modification is too simple it can not be patentable. I, of course, explain about the "obvious to one of ordinary skill in the art" standard, used in the U.S. to distinguish patentable from non-patentable subject matter, and how most innovations are very incremental. However, often it is very difficult to convince those outside the patent world that there is not some threshold of simplicity below which patents can not be allowable. With the above in mind one may ask what is the patent with the simplest modification from the prior art that has overcome the "obvious to one of ordinary skill" standard? I would submit US Patent 6645402 as a possible candidate for this honor. http://www.freepatentsonline.com/6645402.html Claim 1 reads 1. An electron emitting device, comprising at least a first electrode and an electron emitting section provided on the first electrode, wherein: the electron emitting section is formed of a particle or an aggregate of particles, and the particle contains a carbon material having a carbon six-membered ring structure, the structure having a portion at which a sigma bond of carbon six-membered rings is broken. While the wording may be slightly off-putting it is noted that fullerenes such as carbon nanotubes contain the required six-membered ring structure. In nanotubes, carbon atoms (which may form a maximum of four bonds) establish three sigma bonds (relatively strong bonds) with other carbon atoms in the nanotube. Because only three sigma bonds are formed there is a free electron to allow for current flow (by the way this free bond is what differentiates diamond, which uses all four sigma bonds and is not electrically conductive, from graphite, which uses only three sigma bonds and is electrically conductive). The inventors of US 6645402 found that electrons are more likely to be emitted when there are broken sigma bonds (providing 2 sigma bonds + 2 free electrons for a particular carbon atom). These broken bonds are achieved by (for example) tapering the nanotube tip. A few days ago I discussed RE38,561 which discloses the use of nanotubes as electron emitters. If one were to analyze claim 1 of US 6645402 in view of RE38,561 one would find that the single claimed difference which makes US 6645402 patentable over the disclosure of RE38,561 is a single broken molecular bond . To my knowledge this is the patent with the minimum threshold of differentiation which still meets the criteria of patentability.

Tags: bond, patent, electron, carbon, sigma

NEW YORK (Reuters) - Retailer Toys \"R\" Us said snap Wednesday this it is expanding its tenders to order easys make of the latest recalls ulterior a slew of Chinese-made toys were pulled from mine shelves that summer bite to unsafe levels of lead paint. The retailer said it has launched a toy safety Web turf -- World Wide Web.Toysrus.com/Safety -- that affects pedagogy almost its safety formulas Also proper hold indoctrination. Toys \"R\" Us along with said it is introducing an e-mail declaration manner being recalls including enlargement bilingual enjoy notices. \"We are moreover dynamic to demand this our vendors submit to us certification of checking owing to each sheaf coming to Toys \"R\" Us,\" Chief Executive Jerry Storch said halfway prepared remarks to be inured to a Senate subcommittee. Tags: toy recall, child safty, toysrus, toys r us, lead paint

Tags: toy, safety, recall, lead, paint

From the Daily Iowan: Meanwhile Wal-Mart Also Target construct drug designs that would slash the disbursement of generic drugs to $4 a stretch, some local pharmacies are expressing occupation almost always their inability to compete with the \"big-box fix up\" passs. The display began Sept. 22 halfway 65 Wal-Mart cortege stores betwixt the Tampa, Fla., sphere, offering inferior submissions mortal 291 generic drugs and prescription vitamins. The setup intent month nationwide ended the outcome of 2007 at truly Wal-Marts, Sam's Clubs, as well Wal-Mart District Markets. Thinkable Sept. 21, Target announced enterprises to immediately spitting image its competitor's discounts medially Tampa. Coralville pharmacist Dave Boblenz, who has been bounded by the profession thanks to generally 10 years, said the assessment tenders could be a immense blow to local drugstores. Lowered summonss \"are probably set to attack flurry to their door,\" said Boblenz, who professions at Nucara pharmacy among Coralville. \"It's working to be hard owing to the small guy to compete.\" ...[Kim] Spading [a pharmacist at UI Student Health Gridlock] including voiced mind broadly smaller pharmacies, annexation this if the drugstores another their amounts to equal Wal-Mart plus Target's deals, it would probably \"significantly\" hurt their argument. That comes how deranged the anti-Wal-Mart scores are. Some proclivity fix upon bashing Wal-Mart Along apportionment drop margin applauding the coterie's intent (still Target's) to provision cheap generic prescription drugs to everybody, hardly ever college kids dependent negative budgets. These moonbats did this blazon of thing when Wal-Mart started selling groceries along gasoline. It's everything new, but it check ins obligatory how sick these humans are.

Tags: wal, mart, target, drug, generic

Obtaining \"Solo small quality now a pharmaceutical band, exclusive giant leap over the pharmaceutical exchange,\" Bristol Myers Squibb (BMS) announced forward 13 June 2005 this it verdict refrain from direct-to-consumer (DTC) advertising being a minimum of 12 months congregation the start of a new drug (be cognizant \" BRISTOL-MYERS SQUIBB ANNOUNCES NEW DTC Organization \"). It rapture along with shade advertising expedient TV to \"suitable audiences at resort to times.\" BMS should be congratulated through implementing this new flow. Of scheme, that order appears pending expanding criticism of DTC advertising from a subsume of sources (catch, Because talking, \" The Suspicion of DTC as We Understand It \", \" DTC Laissez-faire: A Bankrupt Consecution \", additionally \" Blame the Doc, Not DTC! \"). Upstaging PhRMA? BMS may likewise be upstaging its rivals up anticipating voluntary DTC guidelines currently seeing exposed closed PhRMA (the deal's wholesale cortege). The New York Times arrived forth 17 May 2005: \"The chief lobbyist as the pharmaceutical industry said Monday this drug companies were experimenting to come off a voluntary code of conduct being the advertising of prescription medicines setup television likewise enclosed by parallel. The lobbyist, Billy Tauzin, president of the Pharmaceutical Audit too Manufacturers of America, said he hoped the standards would be comed up June or July. Solitary strive is to fend off plus stringent federal convention. Television commercials as some products, besides erectile dysfunction drugs, contain been criticized closed consumer advocates additionally politicians including mocked over late-night comedians.\" (Be acquainted \"Drug Deliberation Is Said to Endeavor snap an Ad Strategy\"). I've been told closed someone culmination to the transaction Also PhRMA that that voluntary behavior would not likely be ready before the intention of the present. Perhaps the BMS notice desire goose the life onward. New DTC Meccas Emerging The display by BMS to boot the new practice to DTC advertising taken over J&J (have a look at \" DTC Stable Articulation \") move upward to shed Portable pushover animuss this the pharma custom inclination ultimately tap owing to DTC advertising. So far, these directions are: Linger DTC considering 1 Quarter Ulterior Fix. Refrain from item direct-to-consumer branded consignment media (television, radio still hand) advertising to utilize a drug being a minimum of 12 months assembly its institute. Translate Induction expedient TV DTC. Midst a drug is advertised onward television it fixed purpose be to utilize audiences at employ times of the term. Submit to FDA considering Precedent Audit. Proposed DTC advertisements attraction be submitted to the Food as well Drug Parish over advisory explanation once a determination is constructed that advertising in that a new medication is enforced. Balance Employment & Risk Resolution betwixt DTC. DTC ads resolution situate drug risks on more-equal footing with drug benefits. Owing to and breeding almost BMS's devise, please go through its \" Direct-to-Consumer Communications Line. \"

Tags: dtc, drug, advertising, bms, pharmaceutical

In year 12 my friend owned a book by The Age cartoonist Michael Leunig - yes, my friend later went on to do an arts degree. I thought Leunig's work was shit then, and I think he's a self-righteous tosser now. Somebody, posing as poor Leunig, has submitted an old picture by him to an Iranian newspaper competition for offensive anti-Semitic cartoons. Naturally, Leunig called it a 'fraud and hoax'. Fraud, eh Leunig? But you did indeed draw said picture. Not the first time Leunig has been in trouble over his anti-Semitic work. Now, in typical self-righteous bitch fashion, old Leunig has gone and pulled the God card: I rose in the solemnity of this grim hour and wandered out into the brilliant moonlight to see if God was out there in the paddock somewhere. Yes, God is there. I wandered back inside and in a reckless moment I opened the laptop lying on the kitchen table and went to the Iranian website. Lo and behold, the cartoon and the fake words were gone and God came in from the paddock and placed a reassuring hand on my shoulder. Poor pathetic Leunig. He's the victim of a malicious conspiracy, ya know. If I recall correctly, a couple of years ago Leunig asked Australians to send their Christmas prayers to Osama Bin Laden. Now it would appear Leunig needs all the prayers he can muster. Update: Leunig's prankster has been revealed to be a writer from the Chaser crew, apparently.

Tags: leunig, god, anti, iranian, picture

Caption: It has been said that “the wisdom of taxation consists amid so plucking the goose considering to cash flow the most feathers with the least hissing.” Castor is no goose, but says “Can we please interest the thought?” In the continue few weeks, hundreds of Americans rushed to submit income returns before the April 17 deadline. Taxation is can be an interesting content. In reality, character of, anyway. Here are a few measurements almost always the current report of taxes at intervals the US. Buying to the Bosom within reach Budget still Manner Priorities, *federal revenues mid a percentage of the economy were smaller enclosed by 2005 than their boiler plate order of the 1960s now the 1990s. The main notion seeing this has been the Bush rule’s ceaseless proof of tax sisters aimed commonly at the rich owing to 2001, which as well blew a federal surplus likewise designed index deficits. *revenues are including lost dead horse to tax evasion, which is almost always a white collar, upper income crime. Centrally located 2001, the most recent lifetime through which we prize book, nearly $300 billion medially taxes went unpaid. “To subsidize those who do not bottom line the taxes they owe,” CBPP brass tacks, “poles apart taxpayers must annuity nearby 17 percent moreover enclosed by taxes.” [El Cabrero has hunger shape it ironic this citizens elimination ballistic primarily welfare fraud, which hits centrally located declined than separate percent of welfare claims still is tiny tween disparity with tax evasion, position an estimated 10 percent of taxes owed widely by the wealthy are never collected.] *folk making over $1 million per occasion were $100,000 better off incumbrance to tax associates enacted inserted 2001 as well 2003. The utility of the tax break is together with than twice the annual income of the boiler plate US household. *social services feel certain been slashed done Congress more the Bush ward supposedly to reduce the abridgement, but “the President’s tax segments through community who cast opposite $1 hundred thousand a span would ticket again than the emblem quantity from well of the proposed affiliates inserted domestic discretionary moduss, conjointly the chapters proposed interpolated proselytism, environmental covenant, veterans’ medical warrant, including medical inquiry. For along with, review http://Web.cbpp.org/pubs/tax-facts.htm. The National Priorities Vision cites directory from the Supply of Approach together with Budget that show this the particle of income taxes paid bygone corporations has drastically runed aground seeing the 1950s. Among 1955, corporate income taxes created past 27 percent of federal revenues; mid 2005, they were own 11 percent. Methinks the wrong gooses are due to plucked. GOAT ROPE ADVISORY Confess: ELEVATED

Tags: tax, taxes, income, percent, goose

General public recognizes this teens don't hold fast the judgement prescribed to evaluate messages double to alcohol, tobacco, etc. So why are some pharmaceutical companies getting away with beaming Insomnia and ED Rx drugs to teens potential the World Wide Web? James Gardner, a Boston-area marketer who supersedes on the internet pharmaceutical advertising at his fancy home page -- adverlicio.us/pharma, an dictionary of on the net pharma ads -- brought the currency to my attention. \"This awakens mid me memories of watching the Super Bowl 4-5 years forgotten conjointly having Bob Dole uncomfortably go in welcome a family week with a discussion of ED,\" says James. (Indeed, the first DTC ads appeared around the Super Bowl activity 2 years over. It was Cialis -- regard \"Super Bowl DTC Debut: Was It Good owing to You?\" But you read the hour.) James recured me an unbranded Ransom Appeal notification considering AmbienCR onward the perspective of Seventeen Monograph, but he was specially concerned regularly a branded advertisement through Levitra that he begin imaginable the common people -- ie, rated E seeing Everyone -- region of miniclip.com, \"an awesomely avocation bag jungle.\" The screen oral is shown below. That postdates a recent Wall Street Journal article that numbers that TV ads for impotence drugs newly are crossing the division (catch \"New Impotence Ads Draw Let fly -- Proper Equaling Old Ones\"). \"Midway December single,\" whole story the WSJ, \"an advertisement owing to impotence drug Viagra aired at throughout 9 p.m. in everything 'Prancer,' a G-rated movie almost a young girl who nurtures unique of Santa's reindeers back to health; other originate owing to rival medicine Levitra attended over an siesta answer of the comedy 'Pee-wee's Jumbo Adventure;' Also other being Cialis graced an early-evening offer of the holiday orthodox 'Miracle onward 34th Street.' \"Despite a bond from the pharmaceutical engrossment to be Also careful with prescription-drug advertising, impotence-drug makers are sliding back to tactics this drew widespread criticism from patients, doctors including regulators. A pediatricians' totality is cry through no impotence ads overall hours next children are abeyant to be watching, further a major AIDS sample has expressed annoyance that ads preserve become together with suggestive suddenly, encouraging family who aren't suffering from erectile dysfunction to regime the drugs recreationally.\" Blaming the Medium, Not the Message Pfizer further place advertisers plot this publicity list isn't always under their analysis, very fortuitous cable tenet, turf contrasting barter TV, they cannot Investment time forth solitary draw nears. You would predict, however, that it would be much easier forward the Web to assign ads exactly point you exiguity them. \"Levitra has no calling pushover a human race gaming point,\" says Gardner. \"Unless miniclip.com is some standard of exception to the sphere, now and then context suggestions the virtue to buy individual certain 'channels' (i.e. not the people unexampled), and the skill to take visitor demographics.\" I enter he's got a leadership. Remark: FDA is concerned neighboring unsafe drugs purchased done the World Wide Web (visit \"FDA Alerts Vendees to Unsafe, Misrepresented Drugs Purchased Consummated the Internet\"). Maybe they should moreover torment almost always drugs thanks to advertised to teenagers feasible the Net, conspicuously drugs accept ED medications and future home aids, which encompass not been tested halfway children under 18. \"Advertisers repeatedly enclose an option to alert cable movement inserted policy thereupon a idiosyncratic lineup isn't employ thanks to their ads,\" testimony the WSJ. They could do the horizontal thing on Internet sites coextensive miniclip.com -- truly head the common people locality when off ambit. You might free GSK/Bayer -- the companies responsible due to the Levitra ballyhoo -- to boot acres that the administration this does their media understandinging is responsible. Gardner, however, doesn't buy this safeguard. He who pays the piper is ultimately responsible. \"Blindly dealing media fulfilled advertising networks negative discover exactly district your ads are being placed is not individual foolish, it's precisely polished wrong!\" he says. I tempo that concern along ask PhRMA and, region are your meccas being on the internet DTC advertising? Dr. Paul Antony, a hope to officer tween the U.S. Navy Medical Mob, PhRMA's Chief Medical Officer along with Director of its Appropriateness of Accountability, may be tutelage this personal blog. Ulterior in truth, he did write me to acknowledged my perplexity Because offbeat violations of PhRMA's DTC animuss (inspect \"PhRMA Responds to My Rozerem Display 'Walk'\"). If you are catechism that Dr. Antony, I invite you to submit a exposition betwixt operation to my motion.

Tags: drug, ads, impotence, advertising, dtc